Healthier Capital leads $90M Series E for Suki to scale ambient scribe and agentic workflows
Health tech firm Suki secures new funding round led by Healthier Capital to scale its ambient scribe platform and introduce agentic workflows.
Key points
- Suki raised $90 million in a Series E funding round.
- Healthier Capital led the investment round for the health tech company.
- The company projects annual revenue between $60 million and $80 million.
Suki has secured a $90 million Series E funding round led by Healthier Capital, according to a report by Techmeme citing Axios. The health technology company stated the capital will support the scaling of its operations and the development of agentic workflows for its AI ambient scribe platform used by healthcare providers.
What is the financial scope of this investment?
The total amount raised in this Series E round is $90 million. Healthier Capital acted as the lead investor for the transaction. This funding follows previous rounds and represents a significant injection of capital into the company’s balance sheet, allowing for further product development and market expansion within the healthcare sector.
What are the company’s current revenue projections?
A source familiar with the matter indicated to Axios that Suki projects annual revenue between $60 million and $80 million this year. This financial outlook reflects the company’s growth trajectory and the adoption rate of its ambient scribe technology among healthcare providers seeking to streamline documentation processes and reduce administrative burdens.
How will the new funding be utilized?
CEO Punit Soni told Axios that the capital will be used to scale the company’s existing operations and add agentic workflows to its AI scribe offerings. These agentic workflows are designed to enhance the automation capabilities of the platform, allowing it to handle more complex tasks within clinical documentation and potentially improve efficiency for medical professionals using the service.
What does this mean for healthcare organizations?
For healthcare organizations, this funding signals a continued push toward automated clinical documentation solutions. The expansion of agentic workflows suggests that AI tools will become more proactive in managing patient records and administrative tasks. Institutions adopting such technologies may see changes in how clinical data is captured and processed, impacting workflow integration and operational efficiency.
What to do and how to stay safe: Suki
- Review current clinical documentation workflows to identify areas where AI scribes could reduce administrative burden.
- Assess data privacy and security implications of integrating third-party AI tools into electronic health record systems.
- Evaluate the accuracy and reliability of ambient scribe outputs to ensure patient safety and regulatory compliance.
- Monitor vendor updates regarding new agentic capabilities and their potential impact on existing IT infrastructure.
Step-by-step guide: AI Usage Policy Checklist for Secure Enterprise Deployment
General security guidance from the Sandbox Desk newsroom. It is not confirmed advice from the organisations named in this story.
Frequently asked questions
Who led Suki’s latest funding round?
Healthier Capital led the $90 million Series E funding round for Suki.
How much revenue does Suki project for this year?
A source told Axios that Suki projects annual revenue between $60 million and $80 million.
What will Suki use the new funding for?
CEO Punit Soni stated the funds will be used to scale operations and add agentic workflows to the AI scribe platform.
